T cell targeted immunotherapy for autoimmune disease.

about

Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris Priming of autoreactive CD8(+) T cells is inhibited by immunogenic peptides which are competitive for major histocompatibility complex class I binding

P2860

Q33270386-0D03BB98-EFEF-4EC6-A4EC-5AB39BB85063 Q37034101-F53A1628-49C5-49C8-BCBA-0B308E4660C3

P2860

T cell targeted immunotherapy for autoimmune disease.

Item

http://www.wikidata.org/entity/Q36359571

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

T cell targeted immunotherapy for autoimmune disease.

@ast

T cell targeted immunotherapy for autoimmune disease.

@en

type

Item

label

T cell targeted immunotherapy for autoimmune disease.

@ast

T cell targeted immunotherapy for autoimmune disease.

@en

prefLabel

T cell targeted immunotherapy for autoimmune disease.

@ast

T cell targeted immunotherapy for autoimmune disease.

@en

P1476

T cell targeted immunotherapy for autoimmune disease.

@en

P2093

Animesh A Sinha

http://www.w3.org/2001/XMLSchema#string

Erica Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

CTLA-4 ligation blocks CD28-dependent T cell activation

Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus

Natalizumab for active Crohn's disease

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

A new member of the immunoglobulin superfamily--CTLA-4

Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

P304

577-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08916930500418136

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16390811

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

T cell targeted immunotherapy for autoimmune disease.

about

P2860

P2860

T cell targeted immunotherapy for autoimmune disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921